Grade is leaving after a two-year stint defined by changes to Baxter’s business, including the sale of its kidney care unit.
Transition amid governance reviews and safety investigations continues Interim finance chief brings background and public ...
Baxter International (NYSE:BAX) is restructuring its business, including a spin-off of its kidney care unit. The company is realigning its portfolio to concentrate on higher margin medical products.
Baxter International stock has reached a new 52-week low, touching $16.99, bringing the healthcare equipment company’s market capitalization to $8.76 billion. Despite the decline, InvestingPro ...
WITH RECENT DIVESTURE, RESTRUCTURING AND EXECUTIVE MOVES, WHAT'S NEXT FOR BAXTER?: News that Baxter International is selling off its biopharma solutions business for $4.25 billion wasn't surprising as ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be ...
Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources Sale follows robust process focused on maximizing stockholder value Provides ...
Baxter International is a leading manufacturer and supplier of everyday hospital essentials, from IV bags and infusion pumps to smart beds and injectable drugs. Following major divestitures, Baxter is ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Baxter International intends to reduce its global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results